Page last updated: 2024-08-21

alpha-aminopyridine and Adrenal Cortex Cancer

alpha-aminopyridine has been researched along with Adrenal Cortex Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abate, A; Berruti, A; Cosentini, D; Fiorentini, C; Grisanti, S; Grosso, E; Hantel, C; Laganà, M; Memo, M; Rossini, E; Scatolini, M; Sigala, S; Tamburello, M; Tiberio, GAM	1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Adrenal Cortex Cancer

Article	Year
Ribociclib Cytotoxicity Alone or Combined With Progesterone and/or Mitotane in in Vitro Adrenocortical Carcinoma Cells. Endocrinology, 2022, 02-01, Volume: 163, Issue:2 Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aminopyridines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Humans; Mitotane; Progesterone; Purines	2022

Article

Year

Ribociclib Cytotoxicity Alone or Combined With Progesterone and/or Mitotane in in Vitro Adrenocortical Carcinoma Cells.

Endocrinology, 2022, 02-01, Volume: 163, Issue:2

Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aminopyridines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Humans; Mitotane; Progesterone; Purines

2022